EMBL Director General
Collaborative discovery in challenging times
See some highlights from 2020 below or see the full report.
"I truly admire the effort and dedication of staff across EMBL, and no more so than over the past year. Our swift and assured response to the coronavirus pandemic leaves me in no doubt of our ability to provide the knowledge and tools needed to solve challenges of global importance."
EMBL Director General
During the unprecedented challenges of 2020, EMBL took rapid action to ensure the safety of staff and to join the global response to the COVID-19 pandemic.
Our scientists and collaborators discuss how EMBL's state-of-the-art facilities, expertise, and service provision have helped the global community tackle COVID-19.
We carried out numerous projects to understand the biology of the SARS-CoV-2 virus and advance the development of testing methods, treatments, and vaccines.
A focus of our efforts in 2020 was making COVID-19 data easily accessible to the international research and healthcare communities.
EMBL performs fundamental research in molecular biology.
EMBL offers vital services to scientists in EMBL member states and around the world.
EMBL's European Bioinformatics Institute (EMBL-EBI) maintains the world’s most comprehensive range of freely available and up-to-date molecular data resources.
Florent Cipriani, who recently retired as Head of the Instrumentation Team after a long career at EMBL Grenoble, is one of the pioneers of instrumentation development in this field, creating ingenious inventions with worldwide impact.
Cutting-edge electron and light microscopy technologies
We give researchers open access to cutting-edge imaging technologies, integrating methods in light and electron microscopy.
EMBL trains scientists, students, and visitors at all levels.
EMBL service leaders discuss the impact of EMBL’s new fellowship programme for research infrastructure scientists
How EMBL’s ‘Microscope in Action’ introduces teenagers to the basics of fluorescence microscopy
Learning lessons and looking ahead
The coronavirus pandemic has created unprecedented challenges for those trying to organise scientific courses and conferences.
EMBL engages in technology transfer and industry relations.
Leica Microsystems and EMBL have signed a unique long-term framework collaboration agreement to provide new imaging technologies.
ALPX has become the latest spinoff company from EMBL Grenoble.
EMBL’s technology transfer arm, EMBLEM, plays a key role in enabling these activities.
EMBL coordinates and integrates European life science research.
EMBL’s administrative and scientific operations teams provide the foundations for the five missions and enhance EMBL’s activities and policies.